Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
3.390
+0.330 (10.78%)
At close: Mar 9, 2026, 4:00 PM EDT
3.310
-0.080 (-2.36%)
After-hours: Mar 9, 2026, 7:52 PM EDT
Aclaris Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 409 | 326 | 265 | 74 | 1,050 | 890 | |
| Market Cap Growth | 147.77% | 22.88% | 256.84% | -92.92% | 17.97% | 220.59% | |
| Enterprise Value | 260 | 161 | 95 | -110 | 805 | 650 | |
| Last Close Price | 3.39 | 3.01 | 2.48 | 1.05 | 15.75 | 14.54 | |
| PS Ratio | 52.24 | 41.67 | 14.18 | 2.38 | 35.30 | 131.67 | |
| PB Ratio | 3.96 | 3.16 | 1.71 | 0.47 | 5.32 | 4.51 | |
| P/TBV Ratio | 3.97 | 3.16 | 1.71 | 0.47 | 5.51 | 4.68 | |
| EV/Sales Ratio | 33.17 | 20.59 | 5.06 | - | 27.04 | 96.09 | |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | |
| Net Debt / Equity Ratio | -1.45 | -1.45 | -1.29 | -1.13 | -1.15 | -1.13 | |
| Net Debt / EBITDA Ratio | 2.02 | 2.02 | 3.86 | 1.56 | - | 3.42 | |
| Net Debt / FCF Ratio | 3.16 | 3.16 | 9.97 | 2.24 | 3.34 | 4.25 | |
| Asset Turnover | 0.04 | 0.04 | 0.09 | 0.14 | 0.12 | 0.04 | |
| Quick Ratio | 3.36 | 3.36 | 3.99 | 3.86 | 9.94 | 8.38 | |
| Current Ratio | 3.36 | 3.36 | 3.99 | 4.16 | 10.56 | 8.94 | |
| Return on Equity (ROE) | -50.20% | -50.20% | -84.46% | -49.88% | -44.01% | -77.33% | |
| Return on Assets (ROA) | -24.32% | -24.32% | -15.72% | -31.67% | -21.04% | -25.38% | |
| Return on Capital Employed (ROCE) | -56.20% | -56.20% | -27.80% | -68.80% | -36.60% | -28.60% | |
| Earnings Yield | -15.88% | -19.91% | -49.76% | -118.96% | -8.28% | -10.21% | |
| FCF Yield | -11.55% | -14.48% | -7.61% | -107.07% | -6.49% | -5.89% | |
| Buyback Yield / Dilution | -58.56% | -58.56% | -10.73% | -7.05% | -14.95% | -33.36% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.